Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Marks first international filing for Evofem’s single-dose oral treatment
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
BIL also holds an option to increase its equity stake by an additional 15%
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
 
        Subscribe To Our Newsletter & Stay Updated